Numerous studies have demonstrated the therapeutic potential of inhibiting these kinases, resulting in sensitization to chemotherapeutic agents.2–5 Moreover, Chk1 and Wee1 inhibitors displayed single agent efficacy in cancer cells with specific defects in DNA repair or in cells that are dependent on a constitutive DNA damage response.6–9. This evidence concerns the gene WEE1 and cancer.